<DOC>
	<DOCNO>NCT01330563</DOCNO>
	<brief_summary>The purpose study assess effect Ketoconazole pharmacokinetic characteristic CKD-501 healthy subject .</brief_summary>
	<brief_title>Drug-drug Interaction Study ( CKD-501 , Ketoconazole )</brief_title>
	<detailed_description>From day 1 day 5 , Ketoconazole 200mg administer twice daily Group 1 patient period 1 . Then day 5 , CKD-501 0.5mg co-administered Group 1 patient period 1 . After 28 day-break , period 2 CKD-501 0.5mg administer day 5 . Period 2 Ketoconazole administer . Group 2 administer reverse order .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Between 20 age 45 year old healthy male 18.5 â‰¤ IBW &lt; 25 Agreement write informed consent Hypersensitivity reaction drug clinically significant hypersensitivity reaction history party Medication drugmediated induction/inhibition metabolic enzyme Midazolam within 1 month may affect clinical trial Subject take abnormal meal affect ADME drug Subject history ( gastric duodenal ulcer , gastrointestinal surgical history except appendectomy ) affect ADME drug Substance abuse , history drug abuse show positive party Continued take caffeine ( caffeine &gt; 5 cup/day ) , drink ( alcohol &gt; 210 g/week ) stop drinking severe heavy smoker ( cigarette &gt; 10 cigarette per day ) clinical trial Previously participate trial within 60 day Previously donate whole blood within 60 day component blood within 30 day Inadequate subject medical examination ( medical history , physical examination , ECG , laboratory test ) within 28 day start administration investigational drug SBP &gt; 140 mmHg , SBP &lt; 90 mmHg DBP &gt; 90 mmHg , DBP &lt; 50 mmHg Pulse &gt; 100 per/min , Pulse &lt; 50 per/min 12lead ECG , QTc &gt; 450 msec An impossible one participate clinical trial investigator 's decision include laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Drug-Drug interaction CKD-501 ketoconazole</keyword>
</DOC>